We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage.
- Authors
Wu, Xiaobing; Guo, Maoni; Cui, Jian; Cai, Haoyang; Wang, San Ming
- Abstract
BRCA1 mutation is the genetic predisposition in causing genome instability towards cancer. BRCA1 mutation is predominantly germline inherited at the fertilization. However, when the inherited mutation initiates genome instability in the mutation carriers remains largely elusive. We used a heterozygotic Brca1-knockout mouse as a model to investigate the issue. Through whole-genome sequencing and bioinformatics analysis, we monitored genome status across the developmental stages from embryo to adulthood in the mouse model. We observed that genome instability as reflected by structural variation, indel and copy number variation already appeared at 10.5-day embryo and progressively towards adulthood. We also observed that the genome instability was not linearly accumulated but dynamically changed along the developmental process, affecting many oncogenic genes and pathways including DNA damage repair, estrogen signaling, and oncogenesis. We further observed that many genome abnormalities in the cancer caused by Brca1 mutation were originated at embryonic stage, and Trp53 (TP53) mutation was not essential for the Brca1 mutation-caused genome instability in the non-cancer cells. Our study revealed that heterozygotic Brca1 mutation alone can cause genome instability at embryonic stage, highlighting that prevention of BRCA1 mutation-related cancer in humans may need to start earlier than currently considered.
- Publication
Oncogenesis, 2022, Vol 11, Issue 1, p1
- ISSN
2157-9024
- Publication type
Article
- DOI
10.1038/s41389-022-00417-3